AzTrials
AzTrials

Dupuytren's DiseaseNCT00575458

Splinting for Dupuytren's Contracture Release

An observational study of Dupuytren's Disease, run by Massachusetts General Hospital at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is comparing two different kinds of splints for patients who have had a surgical contracture release of dupuytren's disease. It compares a static splint and a dynamic splint. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Dupuytren's Disease
How many people
60 participants
Where
1 siteUnited States
Study dates
Jun 2005to Jun 2010
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Orthopaedic Hand Clinic

Who may be able to join

  • 18 years or older
  • males and females with Dupuytren's contracture
  • patients with contracture of less than 30 degrees of MCP contractions and no contractions of the IP joints

Who cannot join

  • previous surgical treatment for Dupuytren's
  • contracture of MCP greater than 30 degrees
  • contraindications for dynamic splinting (upper limb amputees, paresis, ect.)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Massachusetts General Hospital

    Boston, Massachusetts, 02115

Other trials in United States

About this study

Official title: Prospective Randomized Comparison of Dynamic Versus Static Splinting After Dupuytren's Contracture Release

This study is comparing two different kinds of splints for patients who have had a surgical contracture release of dupuytren's disease. It compares a static splint and a dynamic splint.

Medical subject headings
Dupuytren Contracture

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT00575458
Study groupRoleWhat they receive
1Static Splint
2Dynamic Splint

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. DASH questionnaire, PCS questionnaire, Wahler Physical Symptom Inventory, CESD questionnaire

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Dec 2007 (estimated)
  2. Study startJun 2005
  3. Primary completionJun 2010
  4. Study completionJun 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00575458
Sponsor's protocol ID
2005p002466
Status last verified
Nov 2010
First submitted
14 Dec 2007
Last updated
16 Nov 2010
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Dupuytren's Disease, run by Massachusetts General Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Nov 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

DASH questionnaire, PCS questionnaire, Wahler Physical Symptom Inventory, CESD questionnaire (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Nov 2010.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in